Tag: Numinus - Psychedelic Alpha

Our Oregon Local Jurisdiction Tracker is available now.

Read more about the article Numinus Wellness Inc. Reports Q3 2022 Results

Numinus Wellness Inc. Reports Q3 2022 Results

Post published:July 16, 2022
Post category:Press Release

Read more about the article Numinus to Host Q3 2022 Results Conference Call on July 14, 2022

Numinus to Host Q3 2022 Results Conference Call on July 14, 2022

Post published:July 7, 2022
Post category:Press Release

Numinus Unveils New Logo and Brand Identity

Post published:June 28, 2022
Post category:Press Release

Read more about the article Numinus Applies for International Patent Filing of Psychedelics Production Process

Numinus Applies for International Patent Filing of Psychedelics Production Process

Post published:June 22, 2022
Post category:Press Release

Read more about the article Numinus Wellness Inc. Reports Q2 2022 Results

Numinus Wellness Inc. Reports Q2 2022 Results

Post published:April 14, 2022
Post category:Press Release

Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

Post published:April 12, 2022
Post category:Press Release

Numinus Completes First MDMA Administration in PTSD Trial Sponsored by MAPS

Post published:March 30, 2022
Post category:Press Release

Numinus Expands Natural Psychedelic Research with New Biosecurity License

Post published:March 14, 2022
Post category:Press Release

Numinus Adds Ayahuasca & San Pedro to Federal License for Psychedelic Research

Post published:March 9, 2022
Post category:Press Release

Numinus Wellness Announces Voting Results From its Annual General and Special Meeting of Shareholders

Post published:February 28, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.